What is the price targets for Oncolytics Biotech stock?
Based on 2 Wall Street analysts offering 12 month price targets for Oncolytics Biotech in the last 3 months. The average price target is $15.00 with a high forecast of $15.00 and a low forecast of $15.00. The average price target represents a 1036.36% change from the last price of $1.32.
What is the average price target for a stock with a forecast?
The average price target is $15.00 with a high forecast of $15.00 and a low forecast of $15.00. The average price target represents a 1036.36% change from the last price of $1.32. The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Where can I buy Oncy shares?
Shares of ONCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is the marketbeat consensus rating for Oncolytics Biotech?
The consensus rating score for Oncolytics Biotech is 2.50 while the average consensus rating score for medical companies is 2.72. Learn more Do MarketBeat users like Oncolytics Biotech more than its competitors?
Is Oncy stock a buy?
The consensus among 2 Wall Street analysts covering (NASDAQ: ONCY) stock is to Strong Buy ONCY stock.
Where can I Buy ONCY Stock?
Shares of ONCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Should I buy or sell Oncolytics Biotech stock right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oncolytics Biotech in the last year. There are currently...
What is Oncolytics Biotech's stock price forecast for 2022?
4 equities research analysts have issued twelve-month target prices for Oncolytics Biotech's shares. Their forecasts range from $6.00 to $15.00. On...
How has Oncolytics Biotech's stock performed in 2022?
Oncolytics Biotech's stock was trading at $1.39 at the beginning of the year. Since then, ONCY stock has decreased by 24.5% and is now trading at $...
Are investors shorting Oncolytics Biotech?
Oncolytics Biotech saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 213,100 shares, an i...
When is Oncolytics Biotech's next earnings date?
Oncolytics Biotech is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Onc...
How were Oncolytics Biotech's earnings last quarter?
Oncolytics Biotech Inc. (NASDAQ:ONCY) issued its earnings results on Thursday, May, 5th. The company reported ($0.09) earnings per share for the qu...
Who are Oncolytics Biotech's key executives?
Oncolytics Biotech's management team includes the following people: Dr. Matthew C. Coffey M.B.A. , Ph.D., Pres, CEO & Director Mr. Kirk J. Look C...
What is Brad Thompson's approval rating as Oncolytics Biotech's CEO?
2 employees have rated Oncolytics Biotech CEO Brad Thompson on Glassdoor.com . Brad Thompson has an approval rating of 56% among Oncolytics Biotec...
Who are some of Oncolytics Biotech's key competitors?
Some companies that are related to Oncolytics Biotech include Heron Therapeutics (HRTX) , Theratechnologies (THTX) , Nature's Sunshine Products...
What is ONCY’s average 12-month price target, according to analysts?
Based on analyst ratings, Oncolytics Biotech’s 12-month average price target is $15.00.
What is ONCY’s upside potential, based on the analysts’ average price target?
Oncolytics Biotech has 1239.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the [object Object] tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the [object Object] and follow the analysts of your choice. Visit their profiles for more details a...
Stock Price Forecast
Analyst Recommendations
The 4 analysts offering 12-month price forecasts for Oncolytics Biotech Inc have a median target of 6.42, with a high estimate of 15.00 and a low estimate of 4.82. The median estimate represents a +303.56% increase from the last price of 1.59.
Signals & Forecast
The current consensus among 4 polled investment analysts is to Buy stock in Oncolytics Biotech Inc. This rating has held steady since August, when it was unchanged from a Buy rating. Move your mouse over past months for detail
Support, Risk & Stop-loss
The Oncolytics Biotech Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is Oncolytics Biotech Inc. stock A Buy?
Oncolytics Biotech Inc. finds support from accumulated volume at $1.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Golden Star Signal
Oncolytics Biotech Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
